One less? One more.

By   |  June 27, 2008

Gardasil is a vaccine used to prevent most types of cervical cancer caused by the human papillomavirus (HPV), which can be transmitted through sexual intercourse. It’s been pretty heavily publicized through the “One Less” campaign to get girls vaccinated. The key word here is girls because Gardasil is currently only indicated for females 9-26 years old. The logic behind that specific age group is that the vaccine is not effective on exposures prior to getting vaccinated and that by a certain age, one has likely already had a lot of opportunities to come across HPV.

Now Merck, the maker of Gardasil, wants to get FDA approval to have Gardasil indicated for females 27-45 years old. On a side note, it entertains and irks me that being 27 is considered being one of the “older women” as I would like to think that when I’m 27, I’ll still be vibrant and youthful. Seriously though, I have a very hard time believing the vaccine will be as effective in “more established” women just based on logistics of life experience, let alone any kind of metabolic differences that may exist. I suppose with the changing dynamics of sex and marriage, the vaccine could still have some benefit for this proposed age group, but it transparently seems to be a ploy to generate more revenue.

For the girls who are in the “one less” age group but not yet the age of majority, there was a lot of controversy over whether to make vaccination mandatory in certain states. The traditionalist in me has trouble with mandatory vaccination because there are many situations where amazing medical breakthroughs were later found to be harmful (e. g. the Fen-phen diet pills in the 90’s). However, the progressive in me has a hard time with denouncing vaccination or having no governmental promotion of it because there are also situations from the past where we were so sure something was safe but actually was not (e. g. smoking).

As for my female peers in the “one less” age group, now is the time to decide whether Gardasil is for you or now. As a future physician, I just want to be able to present the options as objectively as possible and let each individual decide for herself.

Comments? Leave your intelligent feedback down below or consider following CollegeTimes on Facebook or Twitter to stay updated or to get in touch!

Share This Story:

Page ID #34745  -  Last updated on

Please scroll down to leave a comment.

One Comment on “One less? One more.”  (RSS)

  1. Lol, freudian slip of the tongue there on my part,Auntie Maim.Yes both tortuous and tortious things have gone on here in the “news” dissemination of information.

Leave a Reply

Your email address will not be published.*

You may use these HTML tags and attributes:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>


2019 MBA Admissions Consulting

These days, college is expensive and not the best choice for everyone. But do you know which degree is still highly valuable? That's right, an MBA degree. If you study at a high quality MBA program in the United States, you can use that degree to improve your reputation and career ANYWHERE in the world, unlike law or medical degrees (or worthless degrees from diploma mills). Contact our experts to see if you're a good candidate for our top MBA programs... all our programs are accredited by AACSB! Official MBA partner of The Economist.

[contact-form-7 id='66877' title='Aringo Form']
© 2007-2024 CollegeTimes -->